サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439310

末梢挿入型中心静脈カテーテル（PICC）デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Peripherally Inserted Central Catheter (PICC) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
末梢挿入型中心静脈カテーテル（PICC）デバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢挿入型中心静脈カテーテル（PICC）デバイスの市場規模は、2023年に9億7,613万米ドル、2030年までに13億2,659万米ドルに達し、2024年～2030年の予測期間にCAGRで5.29%の成長が見込まれます。末梢挿入型中心静脈カテーテル（PICC）デバイスの需要は主に、がんや感染症などの罹患率の増加に加え、特に製品ポートフォリオにおける技術の進歩、製品の発売の増加と適切な償還などの要因によって後押しされており、したがって、2024年～2030年の予測期間に末梢挿入型中心静脈カテーテル（PICC）デバイス市場にプラスの市場成長を生み出します。

末梢挿入型中心静脈カテーテル（PICC）の市場力学

がん、感染症などの疾患の継続的な増加が、末梢挿入型中心静脈カテーテル（PICC）市場の成長を促進しています。例えば、International Agency for Research on Cancerが行った調査によると、2020年に世界中で1,930万件の新たながん症例が報告されたと推定されています。

世界保健機関（WHO）（2022）のデータによると、2020年に世界で乳がん226万件、肺がん221万件、大腸がん193万件、前立腺がん141万件、胃がん109万件が報告されました。

また、Global Cancer Observatory（2021）のデータによると、2020年に世界で約54万4,352件の非ホジキンリンパ腫と8万3,087件のホジキンリンパ腫が報告されています。同資料によれば、2020年に世界全体で約47万4,519件の白血病と約17万6,404件の多発性骨髄腫が報告されています。

Global Cancer Observatory（2023）が発表したデータによると、2020年に全世界で約141万件の前立腺がんの新たな症例が報告され、2040年までにこの数は224万件に達すると予測されています。

世界保健機関（WHO）（2022）によると、2020年に世界で約3,770万人がヒト免疫不全ウイルス（HIV）に罹患しています。また、欧州疾病予防管理センター（ECDC）（2021）によると、過去30年間に、WHO European Regionで220万人以上がHIVと診断され、報告されています。2020年、欧州で約10万4,765人が新たにHIVと診断されました。

PICCデバイスは、感染症患者に抗生物質や抗真菌薬を投与するために使用されます。米国疾病予防管理センターが2021年に発表したデータによると、18歳以上の米国成人の47.8％が2020年～2021年にインフルエンザの予防接種を受けています。

しかし、PICCデバイスの使用に伴う合併症や製品リコールの増加が、末梢挿入型中心静脈カテーテル（PICC）デバイス市場の成長を抑制する可能性があります。

末梢挿入型中心静脈カテーテル（PICC）デバイス市場のセグメント分析

末梢挿入型中心静脈カテーテル（PICC）デバイス市場の設計セグメントでは、トリプルルーメンカテゴリが2023年に52.26％の収益シェアを占めました。これは、トリプルルーメンの末梢挿入型中心静脈カテーテル（PICC）デバイスに関連するさまざまな利点によるものと考えられます。

トリプルルーメンPICCは、複数の輸液が必要な場合に適しています。1つのアクセス部位で複数の異なる輸液を行うことができます。各チャネルに別々の輸液が可能です。カニューレ遠位端の異なる位置に3つのチャネルとルーメンがあり、薬剤注入、採血、中心静脈圧（CVP）モニタリングが同時に行えます。

さらに、トリプルルーメンカテーテルは3つの注入チャネルを持ち、複数の治療薬を同時に投与できるため、ICUでもっとも好まれています。トリプルルーメンカテーテルは食道がん患者への薬物投与や必要な輸液に日常的に使用されています。

当レポートでは、世界の末梢挿入型中心静脈カテーテル（PICC）デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 末梢挿入型中心静脈カテーテル（PICC）デバイス市場レポートのイントロダクション

第2章 末梢挿入型中心静脈カテーテル（PICC）デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 末梢挿入型中心静脈カテーテル（PICC）デバイス市場の主な要因の分析

  • 末梢挿入型中心静脈カテーテル（PICC）デバイス市場の促進要因
    • がん、感染症などの疾患の罹患率の増加
    • 有利な償還政策
    • 製品ポートフォリオにおける技術の進歩
  • 末梢挿入型中心静脈カテーテル（PICC）デバイス市場の抑制要因と課題
    • PICCに関連する合併症
    • 製品リコールの増加
  • 末梢挿入型中心静脈カテーテル（PICC）デバイス市場の機会
    • 疎水性ポリウレタンPICCの成長機会
    • カテーテル材料の改良

第5章 末梢挿入型中心静脈カテーテル（PICC）デバイス市場のポーターのファイブフォース分析

第6章 末梢挿入型中心静脈カテーテル（PICC）デバイスの市場レイアウト

  • 製品タイプ別
    • 高圧注入末梢挿入型中心静脈カテーテル（PICC）
    • 非高圧注入/従来式末梢挿入型中心静脈カテーテル（PICC）
  • 設計別
    • シングルルーメン
    • ダブルルーメン
    • トリプルルーメン
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • その他
  • 地域別
    • 北米の末梢挿入型中心静脈カテーテル（PICC）デバイスの市場規模（2021年～2030年）
    • 欧州の末梢挿入型中心静脈カテーテル（PICC）デバイスの市場規模（2021年～2030年）
    • アジア太平洋の末梢挿入型中心静脈カテーテル（PICC）デバイスの市場規模（2021年～2030年）
    • その他の地域の末梢挿入型中心静脈カテーテル（PICC）デバイスの市場規模（2021年～2030年）

第7章 末梢挿入型中心静脈カテーテル（PICC）デバイス市場の企業と製品のプロファイル

  • B. Braun Melsungen AG
  • AngioDynamics
  • Cardinal Health
  • BD
  • Teleflex Incorporated
  • Argon Medical
  • Cook Group
  • ICU Medical Inc.
  • Medical Components Inc.
  • Access Vascular
  • Vygon
  • Meditech Devices
  • Biowy Corporation
  • Polymedicure
  • Footprint Medical Inc.
  • SILMAG GROUP
  • pfm medical ag
  • Healthline Medical Products
  • INSUNG MEDICAL Co., Ltd.
  • Equipos de Biomedicina de Mexico, S.A. de C.V

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Peripherally Inserted Central Catheter (PICC) Devices Market in Global (2021-2030)
  • Table 3: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Product Type (2021-2030)
  • Table 4: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Design (2021-2030)
  • Table 5: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by End-User (2021-2030)
  • Table 6: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Geography (2021-2030)
  • Table 7: Peripherally Inserted Central Catheter (PICC) Devices Market in North America (2021-2030)
  • Table 8: Peripherally Inserted Central Catheter (PICC) Devices Market in the US (2021-2030)
  • Table 9: Peripherally Inserted Central Catheter (PICC) Devices Market in Canada (2021-2030)
  • Table 10: Peripherally Inserted Central Catheter (PICC) Devices Market in Mexico (2021-2030)
  • Table 11: Peripherally Inserted Central Catheter (PICC) Devices Market in Europe (2021-2030)
  • Table 12: Peripherally Inserted Central Catheter (PICC) Devices Market in France (2021-2030)
  • Table 13: Peripherally Inserted Central Catheter (PICC) Devices Market in Germany (2021-2030)
  • Table 14: Peripherally Inserted Central Catheter (PICC) Devices Market in the United Kingdom (2021-2030)
  • Table 15: Peripherally Inserted Central Catheter (PICC) Devices Market in Italy (2021-2030)
  • Table 16: Peripherally Inserted Central Catheter (PICC) Devices Market in Spain (2021-2030)
  • Table 17: Peripherally Inserted Central Catheter (PICC) Devices Market in the Rest of Europe (2021-2030)
  • Table 18: Peripherally Inserted Central Catheter (PICC) Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Peripherally Inserted Central Catheter (PICC) Devices Market in China (2021-2030)
  • Table 20: Peripherally Inserted Central Catheter (PICC) Devices Market in Japan (2021-2030)
  • Table 21: Peripherally Inserted Central Catheter (PICC) Devices Market in India (2021-2030)
  • Table 22: Peripherally Inserted Central Catheter (PICC) Devices Market in Australia (2021-2030)
  • Table 23: Peripherally Inserted Central Catheter (PICC) Devices Market in South Korea (2021-2030)
  • Table 24: Peripherally Inserted Central Catheter (PICC) Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Peripherally Inserted Central Catheter (PICC) Devices Market in the Rest of the World (2021-2030)
  • Table 26: Peripherally Inserted Central Catheter (PICC) Devices Market in the Middle East (2021-2030)
  • Table 27: Peripherally Inserted Central Catheter (PICC) Devices Market in Africa (2021-2030)
  • Table 28: Peripherally Inserted Central Catheter (PICC) Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Peripherally Inserted Central Catheter (PICC) Devices Market in Global (2021-2030)
  • Figure 3: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Design (2021-2030)
  • Figure 5: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by End-User (2021-2030)
  • Figure 6: Peripherally Inserted Central Catheter (PICC) Devices Market in Global by Geography (2021-2030)
  • Figure 7: Peripherally Inserted Central Catheter (PICC) Devices Market in North America (2021-2030)
  • Figure 8: Peripherally Inserted Central Catheter (PICC) Devices Market in the US (2021-2030)
  • Figure 9: Peripherally Inserted Central Catheter (PICC) Devices Market in Canada (2021-2030)
  • Figure 10: Peripherally Inserted Central Catheter (PICC) Devices Market in Mexico (2021-2030)
  • Figure 11: Peripherally Inserted Central Catheter (PICC) Devices Market in Europe (2021-2030)
  • Figure 12: Peripherally Inserted Central Catheter (PICC) Devices Market in France (2021-2030)
  • Figure 13: Peripherally Inserted Central Catheter (PICC) Devices Market in Germany (2021-2030)
  • Figure 14: Peripherally Inserted Central Catheter (PICC) Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Peripherally Inserted Central Catheter (PICC) Devices Market in Italy (2021-2030)
  • Figure 16: Peripherally Inserted Central Catheter (PICC) Devices Market in Spain (2021-2030)
  • Figure 17: Peripherally Inserted Central Catheter (PICC) Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Peripherally Inserted Central Catheter (PICC) Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Peripherally Inserted Central Catheter (PICC) Devices Market in China (2021-2030)
  • Figure 20: Peripherally Inserted Central Catheter (PICC) Devices Market in Japan (2021-2030)
  • Figure 21: Peripherally Inserted Central Catheter (PICC) Devices Market in India (2021-2030)
  • Figure 22: Peripherally Inserted Central Catheter (PICC) Devices Market in Australia (2021-2030)
  • Figure 23: Peripherally Inserted Central Catheter (PICC) Devices Market in South Korea (2021-2030)
  • Figure 24: Peripherally Inserted Central Catheter (PICC) Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Peripherally Inserted Central Catheter (PICC) Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Peripherally Inserted Central Catheter (PICC) Devices Market in the Middle East (2021-2030)
  • Figure 27: Peripherally Inserted Central Catheter (PICC) Devices Market in Africa (2021-2030)
  • Figure 28: Peripherally Inserted Central Catheter (PICC) Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0101

Peripherally Inserted Central Catheter (PICC) Devices Market By Product Type (Power Injected Peripherally Inserted Catheters, Non-Power Injected/ Conventional Peripherally Inserted Central Catheters), Design (Single Lumen, Double Lumen, Triple Lumen), End-User (Hospitals, Ambulatory Surgical Centers, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of cancers and infectious diseases and the various technological advancements in product portfolio

The global Peripherally Inserted Central Catheter (PICC) Devices market was valued at USD 976.13 million in 2023, growing at a CAGR of 5.29% during the forecast period from 2024 to 2030 to reach USD 1,326.59 million by 2030. The demand for peripherally inserted central catheter devices is primarily being boosted owing to the key factors such as the increasing incidence of cancers, and infectious diseases, among others, technological advancements in product portfolio, and proper reimbursement coupled with increasing product launches, thus creating a positive market growth for the Peripherally Inserted Central Catheter (PICC) Devices market during the forecast period from 2024-2030.

Peripherally Inserted Central Catheter (PICC) Devices Market Dynamics:

The continuous rise in the cases of cancer, infectious, and other diseases is driving the growth of the peripherally inserted central catheter devices market. For instance, the study conducted by the International Agency for Research on Cancer mentioned that worldwide, an estimated number of 19.3 million new cancer cases were reported in 2020.

According to data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

Also, as per the Global Cancer Observatory 2021 data, globally around 544,352 cases of Non-Hodgkin lymphoma and 83,087 cases of Hodgkin lymphoma were reported in 2020. As per the same source globally around 474,519 leukemia cases and nearly 176,404 cases of multiple myeloma were reported in 2020.

The data published by Global Cancer Observatory (2023) says that globally around 1.41 million new cases of prostate cancer were reported in 2020 and by 2040 this number is expected to reach 2.24 million.

According to World Health Organization (WHO) 2022, globally there were around 37.7 million people suffering from human immunodeficiency virus (HIV) in year 2020. Also, as per the European Centre for Disease Prevention and Control (ECDC) 2021, over the course of the last three decades, over 2.2 million people have been diagnosed and reported with HIV in the WHO European Region. In 2020, nearly 104,765 people were newly diagnosed with HIV in the European region.

PICC devices are employed in delivery of antibiotics and antifungal medicines in patients suffering from infectious diseases. According to the data cited in 2021 by Centers for Disease Control and Prevention, 47.8% percent of US adults aged 18 and over received an influenza vaccination in the 2020-2021 duration.

However, complications associated with the use of PICC devices and the increasing number of product recalls may restrict the growth of the peripherally inserted central catheter devices market.

Peripherally Inserted Central Catheter (PICC) Devices Market Segment Analysis:

Peripherally Inserted Central Catheter (PICC) Devices market By Product type (Power Injected Peripherally Inserted Catheters, Non-Power Injected/ Conventional Peripherally Inserted Central Catheters), Design (Single Lumen, Double Lumen, Triple Lumen), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the design segment of the peripherally inserted central catheter devices market, the triple lumen category held a revenue share of 52.26% in the year 2023. This can be ascribed to the various advantages associated with triple lumen peripherally inserted central catheter (PICC) devices.

Triple lumen PICC are suitable for use when multiple infusions are required to be performed. It allows to run several different infusion with only one access site. It offers separate infusion for each channel. It has three channels and lumens present at different positions on the distal cannula which provide ports for simultaneous drug infusion, blood drawing, and central venous pressure (CVP) monitoring.

Moreover, triple lumen catheters are most preferred ICU settings for their three infusion channels that allows for simultaneous administration of multiple therapies. Triple lumen catheters are routinely employed for the delivery of medications and other necessary fluids to patients with esophageal cancer.

In patients under intensive care and patients undergoing bone marrow transplants (BMT), triple lumen catheters are mostly preferred over other types. For example, Poly Per-Q-Cath3 by BD is an example of triple lumen catheter indicated for short or long term peripheral access to the central venous system for intravenous therapy and blood sampling.

Therefore, owing to the above-mentioned factors, the triple lumen category is expected to hold a respectable revenue share in the peripherally inserted central catheter (PICC) devices market during the forecast period.

North America is expected to dominate the overall Peripherally Inserted Central Catheter (PICC) Devices Market:

In the PICC devices global market, North America is expected to hold the largest share of 46.65% in the year 2023. Owing to the significance of key growth factors such as the increasing incidence of cancer, infectious, and other diseases, along with their risk factors, increasing healthcare expenditure, favorable reimbursement policies, rising research and development activities in the region including launches and approvals, among others, the market for peripherally inserted central catheter devices is expected to witness prosperity in the region during the forecast period from 2024-2030.

In the United States, the rising cases of chronic disorders such as cancers, respiratory disorders, gastrointestinal disorders in the region is likely to increase the demand for PICC.

For instance, according to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF), a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States, every year on an average.

In addition, people suffering from cystic fibrosis who need intravenous (IV) antibiotic treatments is for more than just a few days, such as during an exacerbation, which could potentially raise the demand for PICC catheters.

The Public Health Agency of Canada (2023) report stated that in 2020, the rate of active tuberculosis in Canada was 4.7 per 100,000 population. The peripherally inserted central catheters (PICCs) are frequently used to deliver intravenous antimicrobial therapy. Thus, the increasing prevalence of such infections in the country will propel the demand for PICC devices. Canada Institute for Health Information (CIHI) 2023, in 2021-2022, there were almost 2.9 million acute inpatient hospitalizations in Canada, up from 2.7 million visits in 2020-2021. The rising figures of hospitalizations in the country will increase the demand for PICC devices as these devices will be used to administer medications, fluids, and blood products to the hospitalized patients.

Thus, the interplay of all the above-mentioned factors would potentially help in driving the North America Peripherally Inserted Central Catheter (PICC) Devices market forward during the forecast period.

Peripherally Inserted Central Catheter (PICC) Devices Market Key Players:

Some of the key market players operating in the Peripherally Inserted Central Catheter (PICC) Devices market include B. Braun Melsungen AG, AngioDynamics, Cardinal Health, BD, Teleflex Incorporated, Argon Medical, Cook Group, ICU Medical Inc., Medical Components Inc., Access Vascular, Vygon, Meditech Devices, Biowy Corporation, Polymedicure, Footprint Medical Inc., SILMAG GROUP, pfm medical ag, Healthline Medical Products, INSUNG MEDICAL Co., Ltd., Equipos de Biomedicina de Mexico, S.A. de C.V, and others.

Recent Developmental Activities in the Peripherally Inserted Central Catheter (PICC) Devices Market:

In May 2022, Access Vascular, Inc., received the US FDA 510(k) clearance for its HydroPICC® Dual-Lumen catheter which has been designed and constructed using the same proprietary hydrophilic biomaterial as AVI's single-lumen HydroPICC® and HydroMID® catheters, with the aim to reduce complications such as occlusions, replacements, Deep Vein Thrombosis and phlebitis associated with use of multiple lumen catheters.

In March 2020, Biowy PICC-S kit received 510(k) clearance from the US FDA.

In March 2020, Access Vascular, Inc. received FDA clearance for the second generation of its HydroPICC, which demonstrated an average of 97% less thrombus accumulation on its surface compared to a standard polyurethane catheter.

Key Takeaways from the Peripherally Inserted Central Catheter (PICC) Devices Market Report Study

Market size analysis for current Peripherally Inserted Central Catheter (PICC) Devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Peripherally Inserted Central Catheter (PICC) Devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global Peripherally Inserted Central Catheter (PICC) Devices market.

Various opportunities available for the other competitor in the Peripherally Inserted Central Catheter (PICC) Devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current Peripherally Inserted Central Catheter (PICC) Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Peripherally Inserted Central Catheter (PICC) Devices market growth in the coming future?

Target Audience who can be benefited from this Peripherally Inserted Central Catheter (PICC) Devices Market Report Study

Peripherally Inserted Central Catheter (PICC) Devices products providers

Research organizations and consulting companies

Peripherally Inserted Central Catheter (PICC) Devices -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Peripherally Inserted Central Catheter (PICC) Devices

Various End-users who want to know more about the Peripherally Inserted Central Catheter (PICC) Devices market and the latest technological developments in the Peripherally Inserted Central Catheter (PICC) Devices market.

Frequently Asked Questions for the Peripherally Inserted Central Catheter (PICC) Devices Market:

1. What is meant by Peripherally Inserted Central Catheter (PICC) Devices?

Peripherally Inserted Central Catheter (PICC) device is a thin and flexible tube which is inserted into a vein to give intravenous fluids, blood transfusions, chemotherapy, and other drugs.

2. What is the market for global Peripherally Inserted Central Catheter (PICC) Devices?

The global Peripherally Inserted Central Catheter (PICC) devices market was valued at USD 976.13 million in 2023, growing at a CAGR of 5.29% during the forecast period from 2024 to 2030 to reach USD 1,326.59 million by 2030.

3. What are the drivers for the global Peripherally Inserted Central Catheter (PICC) Devices market?

The demand for Peripherally Inserted Central Catheter (PICC) devices is primarily being boosted owing to the key factors such as the increasing incidence of cancer, and infectious diseases, among other, technological advancement in the product portfolio, and proper reimbursement coupled with increasing product launches, thus creating a positive market growth of the Peripherally Inserted Central Catheter (PICC) Devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Peripherally Inserted Central Catheter (PICC) Devices market?

Some of the key market players operating in the Peripherally Inserted Central Catheter (PICC) devices include B. Braun Melsungen AG, AngioDynamics, Cardinal Health, BD, Teleflex Incorporated, Argon Medical, Cook Group, ICU Medical Inc., Medical Components Inc., Access Vascular, Vygon, Meditech Devices, Biowy Corporation, Polymedicure, Footprint Medical Inc., SILMAG GROUP, pfm medical ag, Healthline Medical Products, INSUNG MEDICAL Co., Ltd., Equipos de Biomedicina de Mexico, S.A. de C.V, and others.

5. Which region has the highest share in the Peripherally Inserted Central Catheter (PICC) Devices market?

North America is expected to dominate the overall Peripherally Inserted Central Catheter (PICC) Devices market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the increasing incidence of cancer, infectious, and other diseases, along with their risk factors, increasing healthcare expenditure, favourable reimbursement policies, rising research and development activities in the region including launches and approvals, among others, the market for peripherally inserted central catheter devices is expected to witness prosperity in the region during the forecast period from 2024-2030.

Table of Contents

1.Peripherally Inserted Central Catheter (PICC) Devices Market Report Introduction

2. Peripherally Inserted Central Catheter (PICC) Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Peripherally Inserted Central Catheter (PICC) Devices Market Key Factors Analysis

  • 4.1. Peripherally Inserted Central Catheter (PICC) Devices Market Drivers
    • 4.1.1. Rising incidence of cancer, infectious, and other diseases
    • 4.1.2. Favorable reimbursement policies
    • 4.1.3. Technological advancement in the product portfolio
  • 4.2. Peripherally Inserted Central Catheter (PICC) Devices Market Restraints and Challenges
    • 4.2.1. Complication associated with the PICC
    • 4.2.2. Increasing number of product recalls
  • 4.3. Peripherally Inserted Central Catheter (PICC) Devices Market Opportunities
    • 4.3.1. Growth opportunities in hydrophobic polyurethane PICC
    • 4.3.2. Improvements in catheter materials

5. Peripherally Inserted Central Catheter (PICC) Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Peripherally Inserted Central Catheter (PICC) Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Power Injected Peripherally Inserted Central Catheters
    • 6.1.2. Non-Power Injected/ Conventional Peripherally Inserted Central Catheters
  • 6.2. By Design
    • 6.2.1. Single Lumen
    • 6.2.2. Double Lumen
    • 6.2.3. Triple Lumen
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Peripherally Inserted Central Catheter (PICC) Devices Market Size in USD million (2021-2030)

7. Peripherally Inserted Central Catheter (PICC) Devices Market Company and Product Profiles

  • 7.1. B. Braun Melsungen AG
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. AngioDynamics
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Cardinal Health
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. BD
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Teleflex Incorporated
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Argon Medical
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Cook Group
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. ICU Medical Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medical Components Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Access Vascular
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Vygon
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Meditech Devices
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Biowy Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Polymedicure
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Footprint Medical Inc.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. SILMAG GROUP
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. pfm medical ag
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Healthline Medical Products
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. INSUNG MEDICAL Co., Ltd.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Equipos de Biomedicina de Mexico, S.A. de C.V
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us